Son Yazılar
- Ginseng'in Cinsiyet ve Yaşa Göre Etkileri
- Kalp Sağlığı icin Düzenli Olarak Tüketilmesi Önerilen Sebze ve Meyveler
- Bebeksi Bir Yüz İçin Doğal Çözümler
- Tok Tutan Besinler
- Enerjik ve Zinde Hissettiren Besinler
- Meme Kanserinden Koruyan 7 Besin
- Yaz Aylarinin Sifali Bitkileri
- Yaban Mersininin Faydaları
- Kirazın Faydaları
- Patates suyunun faydaları
- Soğan Suyunun Faydaları
- Kudret Nari - Faydalari ve Kullanimi
- Cevizin Faydalari
Sarımsak
Bitki adı:
Garlic, bulb
Bilimsel adı:
Allium sativum
Cins:
Allium
Familya:
Amaryllidaceae
Diğer adları:
Garlic
SARIMSAK (Yabanî) -Bazı ÂUium (Liliaceae) türlerinin soğan veya yapraklan Anadoluda Sanmsak (A salivu m l) yerine kullanılır. Kullanılan başlıca türler şunlardır. Bk. Soğan. ÂUium ampeloprasum L.-Kaya sarımsağı (Adana). Â. macrochaetum Boiss.et Hau skn. -Kaya sanmsağı (Tunceli). Â. scorodoprasum L.-Taş sarımsağı. Köpek sanmsağı.[Türkçe Bitki Adları Sözlüğü, Turhan Baytop, 2007]
SARIMSAK HARDALI — > Sanmsak otu.[Türkçe Bitki Adları Sözlüğü, Turhan Baytop, 2007]
SARIMSAK OTU -Â iliaria petioiata (Bieb.) Cavara et Grande (Cruciferae). 20-80 cm yükseklikte, iki yıllık, sarımsak kokulu, beyaz çiçekli ve otsu bir bitkidir. Taze yaprakları sarımsak yerine kullanılır. Eş anl. Sarımsak hardalı.[Türkçe Bitki Adları Sözlüğü, Turhan Baytop, 2007]
SARIMSAK SALEBİ— > Deli salep.[Türkçe Bitki Adları Sözlüğü, Turhan Baytop, 2007]
SARIMSAK SOĞANI — > Soğan.[Türkçe Bitki Adları Sözlüğü, Turhan Baytop, 2007]
Genel Bilgiler
(La. Bulbus Allii sativi, Al. Knoblauch, Fr. Ai!, İn. Garlic) Allium sativum L. (Liliaceae) türünün soğanıdır. Bu tür 25 - 100 cm yükseklikte, ye- şiiimsi beyaz veya pembe çiçekli, otsu bir kültür bitkisidir. Nrudir olarak tohum bağlar. 1 - Baytop, T.: Anadolu saparnası (Smilax excelsa L.) üzerinde araştırmalar-Fo!. Farm. 2 : 237 (1953). 2 - Ongan, H.: Ankara'nın 1 numaralı Şer'iye Sicili 24, 64, Ankara (1958).
Kaynak: Türkiye'de Bitkilerle Tedavi (Turhan Baytop), s. 215
Duke – Ethnobotany
Bilgi: Uphof
Kaynak: James A. Duke
Bilgi: Leung
Kaynak: James A. Duke
Bilgi: Duke,1972
Kaynak: James A. Duke
Bilgi: Woi.Syria
Kaynak: James A. Duke
Bilgi: Al-Rawi
Kaynak: James A. Duke
Bilgi: Eb31: 354
Kaynak: James A. Duke
Bilgi: Eb30: 110
Kaynak: James A. Duke
Bilgi: Uphof
Kaynak: James A. Duke
Bilgi: Leung
Kaynak: James A. Duke
Bilgi: Duke,1972
Kaynak: James A. Duke
Bilgi: Brutus
Kaynak: James A. Duke
Bilgi: Eb20: 21
Kaynak: James A. Duke
Bilgi: Leung
Kaynak: James A. Duke
Bilgi: Bliss
Kaynak: James A. Duke
Bilgi: Krochmal
Kaynak: James A. Duke
Bilgi: Uphof
Kaynak: James A. Duke
Bilgi: Bliss
Kaynak: James A. Duke
Bilgi: Duke,1972
Kaynak: James A. Duke
Bilgi: Eb30: 110
Kaynak: James A. Duke
Bilgi: Woi.Syria
Kaynak: James A. Duke
Bilgi: Brutus
Kaynak: James A. Duke
Bilgi: Wong
Kaynak: James A. Duke
Bilgi: Steinmetz
Kaynak: James A. Duke
Bilgi: Eb30: 110
Kaynak: James A. Duke
Bilgi: Wong
Kaynak: James A. Duke
Bilgi: Uphof
Kaynak: James A. Duke
Bilgi: Leung
Kaynak: James A. Duke
Bilgi: Martinez
Kaynak: James A. Duke
Bilgi: Brutus
Kaynak: James A. Duke
Bilgi: Eb30: 110
Kaynak: James A. Duke
Bilgi: Wong
Kaynak: James A. Duke
Bilgi: Tackholm
Kaynak: James A. Duke
Bilgi: Uphof
Kaynak: James A. Duke
Bilgi: Duke,1972
Kaynak: James A. Duke
Bilgi: Eb31: 354
Kaynak: James A. Duke
Bilgi: Krochmal
Kaynak: James A. Duke
Bilgi: Krochmal
Kaynak: James A. Duke
Bilgi: Woi.Syria
Kaynak: James A. Duke
Bilgi: Uphof
Kaynak: James A. Duke
Bilgi: Leung
Kaynak: James A. Duke
Bilgi: Tackholm
Kaynak: James A. Duke
Bilgi: Duke,1972
Kaynak: James A. Duke
Bilgi: Al-Rawi
Kaynak: James A. Duke
Bilgi: Hartwell
Kaynak: James A. Duke
Bilgi: Leung
Kaynak: James A. Duke
Bilgi: Brutus
Kaynak: James A. Duke
Bilgi: Duke,1972
Kaynak: James A. Duke
Bilgi: Eb30: 110
Kaynak: James A. Duke
Bilgi: Al-Rawi
Kaynak: James A. Duke
Bilgi: Wong
Kaynak: James A. Duke
Bilgi: Steinmetz
Kaynak: James A. Duke
Bilgi: Uphof
Kaynak: James A. Duke
Bilgi: Leung
Kaynak: James A. Duke
Bilgi: Duke,1972
Kaynak: James A. Duke
Bilgi: Woi.Syria
Kaynak: James A. Duke
Bilgi: Hartwell
Kaynak: James A. Duke
Bilgi: Hartwell
Kaynak: James A. Duke
Bilgi: Hartwell
Kaynak: James A. Duke
Bilgi: Hartwell
Kaynak: James A. Duke
Bilgi: Uphof
Kaynak: James A. Duke
Bilgi: Leung
Kaynak: James A. Duke
Bilgi: Tackholm
Kaynak: James A. Duke
Bilgi: Leung
Kaynak: James A. Duke
Bilgi: Eb20: 21
Kaynak: James A. Duke
Bilgi: Brutus
Kaynak: James A. Duke
Bilgi: Tackholm
Kaynak: James A. Duke
Bilgi: Uphof
Kaynak: James A. Duke
Bilgi: Duke,1972
Kaynak: James A. Duke
Bilgi: Al-Rawi
Kaynak: James A. Duke
Bilgi: Leung
Kaynak: James A. Duke
Bilgi: Leung
Kaynak: James A. Duke
Bilgi: Al-Rawi
Kaynak: James A. Duke
Bilgi: Leung
Kaynak: James A. Duke
Bilgi: Al-Rawi
Kaynak: James A. Duke
Bilgi: Woi.Syria
Kaynak: James A. Duke
Bilgi: Eb30: 110
Kaynak: James A. Duke
Bilgi: Wong
Kaynak: James A. Duke
Bilgi: Duke,1972
Kaynak: James A. Duke
Bilgi: Uphof
Kaynak: James A. Duke
Bilgi: Duke,1972
Kaynak: James A. Duke
Bilgi: Al-Rawi
Kaynak: James A. Duke
Bilgi: Steinmetz
Kaynak: James A. Duke
Bilgi: Tackholm
Kaynak: James A. Duke
Bilgi: Eb28: 41
Kaynak: James A. Duke
Bilgi: Al-Rawi
Kaynak: James A. Duke
Bilgi: Martinez
Kaynak: James A. Duke
Bilgi: Woi.Syria
Kaynak: James A. Duke
Bilgi: Woi.Syria
Kaynak: James A. Duke
Bilgi: Leung
Kaynak: James A. Duke
Bilgi: Leung
Kaynak: James A. Duke
Bilgi: Uphof
Kaynak: James A. Duke
Bilgi: Leung
Kaynak: James A. Duke
Bilgi: Liogier
Kaynak: James A. Duke
Bilgi: Martinez
Kaynak: James A. Duke
Bilgi: Eb30: 110
Kaynak: James A. Duke
Bilgi: Eb30: 110
Kaynak: James A. Duke
Bilgi: Wong
Kaynak: James A. Duke
Bilgi: Steinmetz
Kaynak: James A. Duke
Bilgi: Uphof
Kaynak: James A. Duke
Bilgi: Leung
Kaynak: James A. Duke
Bilgi: Duke,1972
Kaynak: James A. Duke
Bilgi: Woi.Syria
Kaynak: James A. Duke
Bilgi: Bliss
Kaynak: James A. Duke
Bilgi: Krochmal
Kaynak: James A. Duke
Bilgi: Hartwell
Kaynak: James A. Duke
Bilgi: Woi.Syria
Kaynak: James A. Duke
Bilgi: Woi.Syria
Kaynak: James A. Duke
Bilgi: Tackholm
Kaynak: James A. Duke
Bilgi: Al-Rawi
Kaynak: James A. Duke
Bilgi: Martinez
Kaynak: James A. Duke
Bilgi: Hartwell
Kaynak: James A. Duke
Bilgi: Uphof
Kaynak: James A. Duke
Bilgi: Duke,1972
Kaynak: James A. Duke
Bilgi: Wong
Kaynak: James A. Duke
Bilgi: Eb30: 110
Kaynak: James A. Duke
Bilgi: Brutus
Kaynak: James A. Duke
Bilgi: Eb30: 110
Kaynak: James A. Duke
Bilgi: Leung
Kaynak: James A. Duke
Bilgi: Woi.Syria
Kaynak: James A. Duke
Bilgi: Woi.Syria
Kaynak: James A. Duke
Bilgi: FontQuer
Kaynak: James A. Duke
Bilgi: Brutus
Kaynak: James A. Duke
Bilgi: Martinez
Kaynak: James A. Duke
Bilgi: Hartwell
Kaynak: James A. Duke
Bilgi: Bliss
Kaynak: James A. Duke
Bilgi: Bliss
Kaynak: James A. Duke
Bilgi: Eb24: 354
Kaynak: James A. Duke
Bilgi: Duke,1972
Kaynak: James A. Duke
Bilgi: Liogier
Kaynak: James A. Duke
Bilgi: Brutus
Kaynak: James A. Duke
Bilgi: Leung
Kaynak: James A. Duke
Bilgi: Eb31: 354
Kaynak: James A. Duke
Bilgi: Uphof
Kaynak: James A. Duke
Bilgi: Duke,1972
Kaynak: James A. Duke
Bilgi: Tackholm
Kaynak: James A. Duke
Bilgi: Hartwell
Kaynak: James A. Duke
Bilgi: Bliss
Kaynak: James A. Duke
Bilgi: Brutus
Kaynak: James A. Duke
Bilgi: Woi.Syria
Kaynak: James A. Duke
Bilgi: Al-Rawi
Kaynak: James A. Duke
Bilgi: Al-Rawi
Kaynak: James A. Duke
Bilgi: Bliss
Kaynak: James A. Duke
Bilgi: Uphof
Kaynak: James A. Duke
Bilgi: Eb20: 21
Kaynak: James A. Duke
Bilgi: Duke,1972
Kaynak: James A. Duke
Bilgi: Martinez
Kaynak: James A. Duke
Bilgi: Steinmetz
Kaynak: James A. Duke
Bilgi: Krochmal
Kaynak: James A. Duke
Bilgi: Bliss
Kaynak: James A. Duke
Bilgi: Duke,1972
Kaynak: James A. Duke
Bilgi: Woi.Syria
Kaynak: James A. Duke
Bilgi: Eb28: 41
Kaynak: James A. Duke
Bilgi: Tackholm
Kaynak: James A. Duke
Bilgi: Steinmetz
Kaynak: James A. Duke
Bilgi: Leung
Kaynak: James A. Duke
Bilgi: Leung
Kaynak: James A. Duke
Bilgi: Leung
Kaynak: James A. Duke
Bilgi: Tackholm
Kaynak: James A. Duke
Bilgi: Woi.Syria
Kaynak: James A. Duke
Bilgi: Martinez
Kaynak: James A. Duke
Bilgi: Hartwell
Kaynak: James A. Duke
Bilgi: Hartwell
Kaynak: James A. Duke
Bilgi: Hartwell
Kaynak: James A. Duke
Bilgi: Hartwell
Kaynak: James A. Duke
Bilgi: Leung
Kaynak: James A. Duke
Bilgi: Tackholm
Kaynak: James A. Duke
Bilgi: Tackholm
Kaynak: James A. Duke
Bilgi: Woi.Syria
Kaynak: James A. Duke
Bilgi: Leung
Kaynak: James A. Duke
Bilgi: Steinmetz
Kaynak: James A. Duke
Bilgi: Uphof
Kaynak: James A. Duke
Bilgi: Liogier
Kaynak: James A. Duke
Bilgi: Tackholm
Kaynak: James A. Duke
Bilgi: Duke,1972
Kaynak: James A. Duke
Bilgi: Eb30: 110
Kaynak: James A. Duke
Bilgi: Brutus
Kaynak: James A. Duke
Bilgi: Al-Rawi
Kaynak: James A. Duke
Bilgi: Burkill,1966
Kaynak: James A. Duke
Bilgi: Wong
Kaynak: James A. Duke
Bilgi: Eb30: 110
Kaynak: James A. Duke
Bilgi: Steinmetz
Kaynak: James A. Duke
Bilgi: Krochmal
Kaynak: James A. Duke
Bilgi: Pittier
Kaynak: James A. Duke
Bilgi: Eb31: 354
Kaynak: James A. Duke
Bilgi: Hartwell
Kaynak: James A. Duke
Bilgi: Hartwell
Kaynak: James A. Duke
Bilgi: Hartwell
Kaynak: James A. Duke
Bilgi: Eb30: 110
Kaynak: James A. Duke
Bilgi: Tackholm
Kaynak: James A. Duke
Bilgi: Al-Rawi
Kaynak: James A. Duke
Bilimsel Araştırmalar
Metabolic syndrome (MetS) forms a cluster of metabolic dysregulations including insulin resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis of MetS encompasses multiple genetic and acquired entities that fall under the umbrella of insulin resistance and chronic low-grade inflammation. If left untreated, MetS is significantly associated with an increased risk of developing diabetes and cardiovascular diseases (CVDs). Given that CVDs constitute by far the leading cause of morbidity and mortality worldwide, it has become essential to investigate the role played by MetS in this context to reduce the heavy burden of the disease. As such, and while MetS relatively constitutes a novel clinical entity, the extent of research about the disease has been exponentially growing in the past few decades. However, many aspects of this clinical entity are still not completely understood, and many questions remain unanswered to date. In this review, we provide a historical background and highlight the epidemiology of MetS. We also discuss the current and latest knowledge about the histopathology and pathophysiology of the disease. Finally, we summarize the most recent updates about the management and the prevention of this clinical syndrome.
Makaleyi görüntüle
Makaleyi görüntüle
The use of herbal medicinal products and supplements has increased tremendously over the past three decades with not less than 80% of people worldwide relying on them for some part of primary healthcare. Although therapies involving these agents have shown promising potential with the efficacy of a good number of herbal products clearly established, many of them remain untested and their use are either poorly monitored or not even monitored at all. The consequence of this is an inadequate knowledge of their mode of action, potential adverse reactions, contraindications, and interactions with existing orthodox pharmaceuticals and functional foods to promote both safe and rational use of these agents. Since safety continues to be a major issue with the use of herbal remedies, it becomes imperative, therefore, that relevant regulatory authorities put in place appropriate measures to protect public health by ensuring that all herbal medicines are safe and of suitable quality. This review discusses toxicity-related issues and major safety concerns arising from the use of herbal medicinal products and also highlights some important challenges associated with effective monitoring of their safety.
Makaleyi görüntüle
Makaleyi görüntüle
Essential oils are aromatic and volatile liquids extracted from plants. The chemicals in essential oils are secondary metabolites, which play an important role in plant defense as they often possess antimicrobial properties. The interest in essential oils and their application in food preservation has been amplified in recent years by an increasingly negative consumer perception of synthetic preservatives. Furthermore, food-borne diseases are a growing public health problem worldwide, calling for more effective preservation strategies. The antibacterial properties of essential oils and their constituents have been documented extensively. Pioneering work has also elucidated the mode of action of a few essential oil constituents, but detailed knowledge about most of the compounds' mode of action is still lacking. This knowledge is particularly important to predict their effect on different microorganisms, how they interact with food matrix components, and how they work in combination with other antimicrobial compounds. The main obstacle for using essential oil constituents as food preservatives is that they are most often not potent enough as single components, and they cause negative organoleptic effects when added in sufficient amounts to provide an antimicrobial effect. Exploiting synergies between several compounds has been suggested as a solution to this problem. However, little is known about which interactions lead to synergistic, additive, or antagonistic effects. Such knowledge could contribute to design of new and more potent antimicrobial blends, and to understand the interplay between the constituents of crude essential oils. The purpose of this review is to provide an overview of current knowledge about the antibacterial properties and antibacterial mode of action of essential oils and their constituents, and to identify research avenues that can facilitate implementation of essential oils as natural preservatives in foods.
Makaleyi görüntüle
Makaleyi görüntüle
Cancer prevention and treatment using traditional Chinese medicines have attracted increasing interest. This study characterizes antioxidant activity and phenolic compounds of traditional Chinese medicinal plants associated with anticancer, comprising 112 species from 50 plant families. The improved ABTS(*+) method was used to systematically assess the total antioxidant capacity (Trolox equivalent antioxidant capacity, TEAC) of the medicinal extracts. The TEAC values and total phenolic content for methanolic extracts of herbs ranged from 46.7 to 17,323 micromol Trolox equivalent/100 g dry weight (DW), and from 0.22 to 50.3 g of gallic acid equivalent/100 g DW, respectively. A positive, significant linear relationship between antioxidant activity and total phenolic content (all R(2) values>/=0.95) showed that phenolic compounds were the dominant antioxidant components in the tested medicinal herbs. Major types of phenolic compounds from most of the tested herbs were preliminarily identified and analyzed, and mainly included phenolic acids, flavonoids, tannins, coumarins, lignans, quinones, stilbenes, and curcuminoids. These medicinal herbs exhibited far stronger antioxidant activity and contained significantly higher levels of phenolics than common vegetables and fruits. Traditional Chinese medicinal plants associated with anticancer might be potential sources of potent natural antioxidants and beneficial chemopreventive agents.
Makaleyi görüntüle
Makaleyi görüntüle
The use of and search for drugs and dietary supplements derived from plants have accelerated in recent years. Ethnopharmacologists, botanists, microbiologists, and natural-products chemists are combing the Earth for phytochemicals and "leads" which could be developed for treatment of infectious diseases. While 25 to 50% of current pharmaceuticals are derived from plants, none are used as antimicrobials. Traditional healers have long used plants to prevent or cure infectious conditions; Western medicine is trying to duplicate their successes. Plants are rich in a wide variety of secondary metabolites, such as tannins, terpenoids, alkaloids, and flavonoids, which have been found in vitro to have antimicrobial properties. This review attempts to summarize the current status of botanical screening efforts, as well as in vivo studies of their effectiveness and toxicity. The structure and antimicrobial properties of phytochemicals are also addressed. Since many of these compounds are currently available as unregulated botanical preparations and their use by the public is increasing rapidly, clinicians need to consider the consequences of patients self-medicating with these preparations.
Makaleyi görüntüle
Makaleyi görüntüle
